BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37984295)

  • 1. Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization.
    Ren W; Deng Y; Ward JD; Vairin R; Bai R; Wanniarachchi HI; Hamal KB; Tankoano PE; Tamminga CS; Bueno LMA; Hamel E; Mason RP; Trawick ML; Pinney KG
    Eur J Med Chem; 2024 Jan; 263():115794. PubMed ID: 37984295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure Guided Design, Synthesis, and Biological Evaluation of Oxetane-Containing Indole Analogues.
    Ren W; Vairin R; Ward JD; Francis R; VanNatta J; Bai R; Tankoano PE; Deng Y; Hamel E; Trawick ML; Pinney KG
    Bioorg Med Chem; 2023 Sep; 92():117400. PubMed ID: 37556912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent.
    Hadimani MB; Macdonough MT; Ghatak A; Strecker TE; Lopez R; Sriram M; Nguyen BL; Hall JJ; Kessler RJ; Shirali AR; Liu L; Garner CM; Pettit GR; Hamel E; Chaplin DJ; Mason RP; Trawick ML; Pinney KG
    J Nat Prod; 2013 Sep; 76(9):1668-78. PubMed ID: 24016002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
    Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
    Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3'-hydroxy-4'-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006).
    Macdonough MT; Strecker TE; Hamel E; Hall JJ; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2013 Nov; 21(21):6831-43. PubMed ID: 23993969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Biological Evaluation of Benzocyclooctene-based and Indene-based Anticancer Agents that Function as Inhibitors of Tubulin Polymerization.
    Herdman CA; Strecker TE; Tanpure RP; Chen Z; Winters A; Gerberich J; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
    Medchemcomm; 2016 Dec; 7(12):2418-2427. PubMed ID: 28217276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities.
    Song J; Guan YF; Liu WB; Song CH; Tian XY; Zhu T; Fu XJ; Qi YQ; Zhang SY
    Eur J Med Chem; 2022 Aug; 238():114467. PubMed ID: 35605363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
    Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
    ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization.
    Herdman CA; Devkota L; Lin CM; Niu H; Strecker TE; Lopez R; Liu L; George CS; Tanpure RP; Hamel E; Chaplin DJ; Mason RP; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Dec; 23(24):7497-520. PubMed ID: 26775540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents.
    Maguire CJ; Chen Z; Mocharla VP; Sriram M; Strecker TE; Hamel E; Zhou H; Lopez R; Wang Y; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
    Medchemcomm; 2018 Oct; 9(10):1649-1662. PubMed ID: 30429970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site.
    Li W; Sun H; Xu F; Shuai W; Liu J; Xu S; Yao H; Ma C; Zhu Z; Xu J
    Bioorg Chem; 2019 Apr; 85():49-59. PubMed ID: 30599412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
    Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
    Devkota L; Lin CM; Strecker TE; Wang Y; Tidmore JK; Chen Z; Guddneppanavar R; Jelinek CJ; Lopez R; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2016 Mar; 24(5):938-956. PubMed ID: 26852340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors.
    Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W
    Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors.
    Zhang J; Tan L; Wu C; Li Y; Chen H; Liu Y; Wang Y
    Eur J Med Chem; 2023 Feb; 248():115085. PubMed ID: 36621138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents.
    Tanpure RP; George CS; Strecker TE; Devkota L; Tidmore JK; Lin CM; Herdman CA; Macdonough MT; Sriram M; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2013 Dec; 21(24):8019-32. PubMed ID: 24183586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and screening of novel 4-N-heterocyclic-2-aryl-6,7,8-trimethoxyquinazolines as antiproliferative and tubulin polymerization inhibitors.
    Dwivedi AR; Rawat SS; Kumar V; Kumar N; Anand P; Yadav RP; Baranwal S; Prasad A; Kumar V
    Bioorg Med Chem; 2022 Oct; 72():116976. PubMed ID: 36067627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.